| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
15,937,000 | 16,544,000 | 15,211,000 | 14,878,000 | 15,042,000 |
Cost of Goods Sold (COGS) incl. D&A |
12,643,000 | 13,496,000 | 12,132,000 | 12,120,000 | 12,124,000 |
COGS excluding D&A |
8,501,000 | 11,536,000 | 10,207,000 | 8,037,000 | 8,108,000 |
Depreciation & Amortization Expense |
4,142,000 | 1,960,000 | 1,925,000 | 4,083,000 | 4,016,000 |
Gross Income |
3,294,000 | 3,048,000 | 3,079,000 | 2,758,000 | 2,918,000 |
SG&A Expense |
0 | 0 | 0 | 0 | NA |
Research & Development |
0 | 0 | 0 | 0 | 0 |
Other SG&A |
0 | 0 | 0 | 0 | NA |
Other Operating Expense |
0 | 0 | 0 | 0 | 0 |
Unusual Expense |
103,000 | -29,000 | 17,000 | -34,000 | -121,000 |
Non Operating Income/Expense |
-29,000 | 996,000 | -50,000 | 13,000 | -16,000 |
Equity in Affiliates (Pretax) |
16,000 | 911,000 | 29,000 | 3,000 | 0 |
Interest Expense |
623,000 | 633,000 | 625,000 | 640,000 | 642,000 |
Gross Interest Expense |
623,000 | 633,000 | 625,000 | 640,000 | 642,000 |
Pretax Income |
2,585,000 | 4,383,000 | 2,444,000 | 2,197,000 | 2,381,000 |
Income Tax |
778,000 | 1,405,000 | 811,000 | 750,000 | 801,000 |
Equity in Affiliates |
0 | 0 | 0 | 0 | 5,000 |
Consolidated Net Income |
1,807,000 | 2,978,000 | 1,633,000 | 1,447,000 | 1,585,000 |
Minority Interest Expense |
289,000 | 865,000 | 285,000 | 223,000 | 298,000 |
Net Income |
1,518,000 | 2,113,000 | 1,348,000 | 1,224,000 | 1,287,000 |
Extraordinaries & Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
0 | 0 | NA | NA | 0 |
Net Income After Extraordinaries |
1,518,000 | 2,112,999 | 1,348,000 | 1,224,000 | 1,287,000 |
Preferred Dividends |
0 | 0 | 0 | 0 | 0 |
Net Income available to Common |
1,518,000 | 2,113,000 | 1,348,000 | 1,224,000 | 1,287,000 |
Operational EPS |
0.59 | 0.77 | 0.50 | 0.44 | 0.43 |
EPS (basic) |
0.57 | 0.79 | 0.50 | 0.45 | 0.47 |
EBITDA |
7,436,000 | 5,008,000 | 5,004,000 | 6,841,000 | 6,934,000 |
Depreciation & Amortization Expense |
4,142,000 | 1,960,000 | 1,925,000 | 4,083,000 | 4,016,000 |
Common Shares Outstanding |
2,710,714 | 2,703,000 | 2,717,000 | 2,744,000 | 2,778,000 |
Basic Shares Outstanding |
2,663,157 | 2,668,000 | 2,687,000 | 2,708,000 | 2,746,000 |
Diluted Shares Outstanding |
2,710,714 | 2,703,000 | 2,717,000 | 2,744,000 | 2,778,000 |
Diluted EPS after Extraordinary Items |
0.56 | 0.78 | 0.50 | 0.45 | 0.46 |
Discont. Operations Per Share |
0 | 0 | 0 | 0 | 0 |
Continued operations EPS |
0.57 | 0.79 | 0.50 | 0.45 | 0.47 |
*Figures in thousands of U.S. Dollars except shares outstanding.
